Copper nutriture and ischemic heart disease: a brief review

Main Article Content

Leslie M. Klevay, MD, SD in Hyg., FAAAS, FASN


The idea that dietary fat is poisonous arose nearly ¾ of a century ago. Criteria for associating disease incidence with environmental change were published a couple decades later. Intakes of dietary fat did not increase while ischemic heart disease risk was increasing; in contrast, dietary copper decreased. Intakes of copper calculated from food tables are falsely high by an average of 77%. Approximately half of adults consume less than 0.9 mg of copper per day when chemical analyses are done. This amount is less than nutritional guidelines. When hypercholesterolemia was discovered in copper deficient rats, a search was begun for anatomical, chemical and physiological similarities between animals deficient in copper and people with ischemic heart disease; more than 80 of these similarities have been identified. The copper deficiency theory on the etiology and pathophysiology of ischemic heart disease is the simplest and most general theory that has been proposed because it incorporates other theories on fetal programming, homocysteine and iron overload. It satisfies classical criteria of nutritional deficiency and association of an environmental characteristic with disease prevalence.

Article Details

How to Cite
KLEVAY, Leslie M.. Copper nutriture and ischemic heart disease: a brief review. Medical Research Archives, [S.l.], v. 10, n. 10, oct. 2022. ISSN 2375-1924. Available at: <>. Date accessed: 28 nov. 2022. doi:
Review Articles


1. Hill AB. The environment and disease: Association or causation? Proc Royal Soc Med. 1965;58:295-300.
2. Call DL, Sanchez AM. Trends in fat disappearance in the United States, 1909-65. J Nutr. 1967;93:Suppl-28.
3. Klevay LM. Copper and ischemic heart disease. Biol Trace Element Res. 1983;5:245-255.
4. Klevay LM. Ischemic heart disease as deficiency disease. Cell Mol Biol (Noisy-le-grand). 2004;50(8):877-884.
5. Klevay LM, Forbush J. Copper metabolism and the epidemiology of coronary heart disease. Nutr Rep Intern. 1976;14:221-228.
6. Mann GV. Diet-Heart: end of an era. New Engl J Med. 1977;297:644-650.
7. Kristensen ML, Christensen PM, Hallas J. The effect of statins on average survival in randomised trials, an analysis of end point postponement. BMJ open. 2015;5(9):e007118.
8. Barker DJP. Mothers, babies and health in later life. 2 ed. Edinburgh: Churchill Livingstone; 1998.
9. McCully KS. Homocysteine, vitamins, and prevention of vascular disease. Mil Med 2004;169(4):325-329.
10. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981;1:1293-1294.
11. Sullivan JL. Iron versus cholesterol--perspectives on the iron and heart disease debate. J Clin Epidemiol. 1996;49:1345-1352.
12. Klevay LM. Ischaemic heart disease from copper deficiency: a unified theory. Nutr Res Rev. 2016;29(2):172-179.
13. Kuhn TS. The Structure of Scientific Revolutions. 2 ed. Chicago: The University of Chicago Press; 1970., p. 59, 95, 154, 169.
14. Klevay LM. Hypercholesterolemia in rats produced by an increase in the ratio of zinc to copper ingested. Am J Clin Nutr. 1973;26:1060-1068.
15. Selye H. From Dream to Discovery. 1 ed. New York: McGraw-Hill Book Co.; 1964, p. .101-105
16. Klevay LM. Trace element and mineral nutrition in disease: Ischemic heart disease. In: Bogden JD, Klevay LM, eds. Clinical nutrition of the essential trace elements and minerals: The guide for health professionals. 1 ed. Totowa, NJ: Humana Press Inc.; 2000:251-271.
17. Klevay LM. Advances in cardiovascular-copper research. In: Schrauzer GN, ed. Trace elements in nutrition, health and disease. Montreal, Canada: Institut Rosell; 2002:64-71.
18. Klevay LM. How dietary deficiency, genes and a toxin can cooperate to produce arteriosclerosis and ischemic heart disease. Cell Mol Biol(Noisy-le-grand). 2006;52:11-15.
19. Borowczyk K, Piechocka J, Glowacki R, et al. Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial. J Intern Med. 2019;285(2):232-244.
20. Klevay LM. Copper deficiency, heart disease and homocysteine thiolactone. J Intern Med. 2020:May 4. doi: 10.1111/joim.13076. Online ahead of print.
21. Lavi S, Yang EH, Prasad A, et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension. 2008;51(1):127-133.
22. Lynch SM, Frei B, Morrow JD, et al. Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arteriosclerosis, Thromb Vasr Biol. 1997;17(11):2975-2981.
23. Tivesten A, Vandenput L, Carlzon D, et al. Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men. J Am Coll Cardiol. 2014;64(17):1801-1810.
24. Klevay LM, Christopherson DM. Copper deficiency halves serum dehydroepiandrosterone in rats. J Trace Elem Med Biol. 2000;14(3):143-145.
25. Insull W, Jr. Coronary Risk Handbook. New York: American Heart Association; 1973.
26. Cai A, Li G, Chen J, et al. Glycated hemoglobin level is significantly associated with the severity of coronary artery disease in non-diabetic adults. Lipids Health Dis. 2014;13:181.
27. Ewid M, Sherif H, Billah SMB, et al. Glycated hemoglobin predicts coronary artery disease in non-diabetic adults. BMC Cardiovasc Disord. 2019;19(1):309.
28. Klevay LM. An increase in glycosylated hemoglobin in rats deficient in copper. Nutr Rep Int . 1982;26:329-334.
29. Klevay LM. Is the Western diet adequate in copper? J Trace Elem Med Biol. 2011;25(4):204-212.
30. Anon. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. In. Washington, D.C.: National Academy Press; 2001:224-257.
31. Klevay LM, Inman L, Johnson LK, et al. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism: Clin Exper. 1984;33:1112-1118.
32. Klevay LM. Searching for people low in copper. Metabolism. 2012;61(9):1201-1204.
33. Golden MHN. Severe malnutrition. In: Weatherall DJ, Ledingham JG, Warrell DA, eds. Oxford Textbook of Medicine. Vol 1. 3 ed. Oxford: Oxford University Press; 1996:1278-1296.
34. Oster O, Dahm M, Oelert H. Element concentrations (selenium, copper, zinc, iron, magnesium, potassium, phosphorous) in heart tissue of patients with coronary heart disease correlated with physiological parameters of the heart. Eur Heart J. 1993;14:770-774.
35. Spencer JC. Direct relationship between the body's copper/zinc ratio, ventricular beats, and sudden coronary death. Am J Clin Nutr.. 1979;32:1184-1185.
36. Witte KLA, Nikitin,N.P., Parker, A. C., von Haehling, S., Volk, H.-D., Anker, S.D., Clark,A.L., Cleland, J.G.F. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J. 2005;26:2238-2244.
37. Owen CA, Jr. Biochemical aspects of copper. 1 ed. Park Ridge, N.J.: Noyes Publications; 1982.
38. Davis GK, Mertz W. Copper. In: Mertz W, ed. Trace Elements in Human and Animal Nutrition. Vol 1. 5 ed. San Diego: Academic Press; 1987.
39. Klevay LM. Diagnosis of copper deficiency (Rapid responce to Chhertri,SK, et al. Published 2014 Jun 17. doi:10:1136/bmj.g3691). BMJ, 2014: . 2014;BMJ 2014;348:g3691, click Copper deficiency I The BMJ, and Responses.
40. Klevay LM. Improving accuracy of normal serum copper. J Trace Elem Med Biol. 2016;34:38.
41. Klevay LM. Copper. In: Coates PM, Betz, J.M., Blackman,M.R., Cragg, G.M., Levine,M., Moss, J., White, J.D., ed. Encyclopedia of Dietary Supplements. 2 ed. London: Informa Healthcare; 2010:175-184.